Adamantylamide dipeptide stimulates hematopoiesis and increases survival in irradiated mice

International Journal of Immunopharmacology

Volumn 22, Issue 1, 2000, Pages 91-97

  Hofer, M ^a   Vacek, A ^a   Masek K ^b   Juchelkova L ^a   Pipalova I ^a  

^a INSTITUTE OF BIOPHYSICS   (Czech Republic)

^b INSTITUTE OF MATHEMATICS   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYL DEXTRO ISOGLUTAMINE 1 ADAMANTYLAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL SURVIVAL; DOSE RESPONSE; FEMALE; HEMATOPOIESIS; IMMUNOMODULATION; IMMUNOSTIMULATION; IONIZING RADIATION; IRRADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; SURVIVAL RATE; SURVIVAL TIME;

ADJUVANTS, IMMUNOLOGIC; AMANTADINE; ANIMALS; DIPEPTIDES; FEMALE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; MICE; MICE, INBRED C57BL; MICE, INBRED CBA;

EID: 0033953182     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(99)00072-7     Document Type: Article

References (11)

1. Mašek K., Seifert J., Flegel M., Krojidlo M., Kolínský J. The immunomodulatory property of a novel synthetic compound adamantylamide dipeptide. Meth. Find. Exp. Clin. Pharmacol. 6:1984;667-669.
2. Masihi K.N., Lange W., Rohde-Schulz B., Mašek K. Antiviral activity of immunomodulator adamantylamide dipeptide. Int. J. Immunother. 3:1987;89-95.
3. Masihi K.N., Mašek K. Effect of the synthetic immunomodulator adamantylamide dipeptide on replication of human immunodeficiency virus alone or in combination with azidothymidine. Int. J. Immunother. 9:1993;143-150.
4. Franěk J., Malina J. Immunomodulatory capacity of drugs evaluated in a mouse model of Klebsiella pneumoniae infection. Masihi K.N., Lange W. Immunotherapeutic prospects of infectious diseases. 1990;55-58 Springer-Verlag, Berlin, Heidelberg.
5. Farghali H., Buchar E., Jiřička Z., Kameníková L., Janků I., et al. The hepatoprotective effect of a new immunomodulator adamantylamide dipeptide on carbon tetrachloride toxicity in rats. Highlights Modern Biochem. 2:1989;1539-1548.
6. Mašek K. Immunopharmacological properties of synthetic muramyl peptides and their analogs. Masihi K.N., Lange W. Immunomodulators and nonspecific host defence mechanisms against microbial infections. Adv. Biosci. 68:1988;11-19.
7. Fedoročko P. Liposomal muramyl tripeptide phosphatidylethanolamine (MTP-PE) promotes hematopoietic recovery in irradiated mouse. Int. J. Radiat. Biol. 65:1994;465-475.
8. Turánek J., Záluská D., Hofer M., Vacek A., Ledvina M., et al. Stimulation of hemopoiesis and protection of mice against radiation injury by synthetic analogues of muramyldipeptide incorporated in liposomes. Int. J. Immunopharmac. 19:1997;611-617.
9. Vacek A., Hofer M., Mašek K. Effects of in vivo administration of adamantylamide dipeptide on bone marrow granulocyte-macrophage hemopoietic progenitor cells (GM-CFC) and on ability of serum of the treated mice to stimulate GM-CFC colony formation in vitro: comparison with muramyl dipeptide and glucan. Immunopharmacol. Immunotoxicol. 21:1999;1-14.
10. Till J.E., McCulloch E.A. Early repair processes in marrow cells irradiated and proliferating in vivo. Radiat. Res. 18:1963;96-105.
11. Vacek A., Rotkovská D., Bartoníčková A. Radioprotection of hemopoiesis conferred by aqueous extract from chlorococcal algae (Ivastimul) administered to mice before irradiation. Exp. Hematol. 18:1992;234-237.